RESUMEN
AIMS: We aimed to evaluate some specific conditions for growth of Pediococcus pentosaceus ST65ACC and its bacteriocin expression through ABC transporters; to purify the bacteriocin and determine its sequence; and to evaluate the cytotoxicity potential of the purified bacteriocin(s). METHODS AND RESULTS: The results presented for growth behaviour of P. pentosaceus ST65ACC showed that the bacterial growth was slightly influenced when cultured in MRS broth with different amounts of inoculum: 1, 2, 5 and 10%. The bacteriocin activity increased when 5 and 10% inocula were used. The carbon source (glucose) used in different amounts (1, 2, 3 or 4%) had no significant effect on growth and bacteriocin production. The studied strain P. pentosaceus ST65ACC was able to metabolize xylooligosaccharide (XOS) as the sole carbon source, resulting in the production of an antimicrobial peptide. The genes involved in the ABC transport system and sugar metabolism of P. pentosaceus ST65ACC were expressed at different levels. The bacteriocin produced by P. pentosaceus ST65ACC was partially purified by precipitation with ammonium sulphate (40% saturation), followed by reversed-phase liquid chromatography, resulting in the identification of an active bacteriocin. Tandem mass spectrometry was used to identify the partial sequence KYYGNGVTCGKHSCSVDWGK sharing high similarity to coagulin A. The semi-purified bacteriocin had low cytotoxicity based on estimated values for maximal nontoxic concentration (MNC) and cytotoxicity concentration (CC50 ). CONCLUSIONS: The bacteriocin produced by P. pentosaceus ST65ACC is similar to coagulin, with low cytotoxicity, strong antimicrobial activity and possible additional metabolite routes in the producer cell. In addition to MRS broth, bacteriocin was produced also in medium containing XOS (as the single carbon source). SIGNIFICANCE AND IMPACT OF THE STUDY: To the best of our knowledge, this is the first report of evaluation of the role of ABC transporters in the expression of bacteriocin by P. pentosaceus, cultured in MRS and XOS.
Asunto(s)
Bacteriocinas/genética , Queso/microbiología , Leche/microbiología , Pediococcus pentosaceus/metabolismo , Animales , Antibacterianos/química , Antibacterianos/aislamiento & purificación , Antibacterianos/farmacología , Bacteriocinas/biosíntesis , Bacteriocinas/aislamiento & purificación , Bacteriocinas/farmacología , Expresión Génica , Concentración de Iones de Hidrógeno , Pediococcus pentosaceus/química , Pediococcus pentosaceus/genética , Pediococcus pentosaceus/crecimiento & desarrolloRESUMEN
OBJECTIVE: To determine the hospital cost and distribution of financial charges for the initial hospitalization of the surviving periviable neonate. STUDY DESIGN: In this retrospective case series, we analyzed medical records and financial data for neonates 23-25 weeks' gestational age in a single tertiary care NICU over 42 months. A detailed breakdown of hospital cost components and charges was determined for all survivors during their initial hospitalization. Statistical significance was determined using the Bonferroni-Sidak method. RESULTS: Overall survival was 78% in infants born at 23-25 weeks' gestational age. Survival increased and length of stay and hospital costs decreased with increased gestational age (pâ<â0.05 for all). Hospital charges were distributed as: NICU 56%, respiratory 11%, pharmacy 6%, laboratory 6%, radiology 6%, surgery 1%, neonatology 13% and miscellaneous 1%. CONCLUSION: Our study describes the hospital cost and distribution of charges for the periviable neonate during the initial hospitalization. These economic data may guide clinicians in quality improvement and cost management.
Asunto(s)
Viabilidad Fetal , Costos de la Atención en Salud/estadística & datos numéricos , Hospitalización/economía , Recien Nacido con Peso al Nacer Extremadamente Bajo , Recien Nacido Extremadamente Prematuro , Unidades de Cuidado Intensivo Neonatal/economía , Tiempo de Internación/economía , Análisis Costo-Beneficio , Edad Gestacional , Humanos , Recién Nacido , Estudios Retrospectivos , Análisis de Supervivencia , Estados UnidosRESUMEN
Novel polyphosphoesters containing anthracene-derived aminophosphonate units, poly(oxyethylene aminophosphonate)s (4 and 5) and poly[oxyethylene(aminophosphonate-co-H-phosphonate)]s (6 and 7), were synthesized via an addition of poly(oxyethylene H-phosphonate)s to 9-anthrylidene-p-toluidine. The IR, NMR ((1)H, (13)C and (31)P) and fluorescence emission spectral data of the polymers are presented. The copolymers 6 and 7 were tested for in vitro antitumor activity on a panel of seven human epithelial cancer cell lines. Safety testing was performed both in vitro (3T3 NRU test) and in vivo on ICR mice for genotoxicity and antiproliferative activity. The copolymer 7 showed excellent antiproliferative activity to HBL-100, MDA-MB-231, MCF-7 and HepG2 cell lines. However, the in vitro safety testing revealed significant toxicity to Balb/c 3T3 mouse embryo cells. In contrast, the copolymer 6 showed complete absence of cytotoxicity to Balb/c 3T3 cells, but inhibited the growth of breast cancer cells, cervical carcinoma cells (HeLa) and hepatocellular carcinoma cell cultures after prolonged (72h) exposure. The polymers (4-6) exhibited low (4 and 6) to moderate (5) clastogenicity in vivo and slightly inhibited bone marrow cell division, compared to Mitomycin C. The subcellular distribution of the copolymers 6 and 7 were studied in model cell culture systems. The tested polyphosphoesters are expected to act in vivo as prodrugs of aminophosphonates and could be valuable as a new class of biodegradable polymer drug carriers.
Asunto(s)
Antracenos/química , Antimitóticos/farmacología , Antineoplásicos/farmacología , Organofosfonatos/farmacología , Animales , Antimitóticos/administración & dosificación , Antimitóticos/síntesis química , Antineoplásicos/administración & dosificación , Antineoplásicos/síntesis química , Células 3T3 BALB , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Ensayos de Selección de Medicamentos Antitumorales , Femenino , Células Hep G2 , Humanos , Células MCF-7 , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos ICR , Mitosis/efectos de los fármacos , Estructura Molecular , Organofosfonatos/administración & dosificación , Organofosfonatos/síntesis química , Relación Estructura-ActividadRESUMEN
Thymic stromal lymphopoietin (TSLP) is produced by epithelial cells and keratinocytes, and is involved in immune homeostasis or inflammation. The mechanism through which TSLP regulates intestinal inflammation is unclear. Here, we report that mouse dendritic cells (DCs) express TSLP both in vitro and in vivo in response to Toll-like receptor ligation in a MyD88-dependent fashion. TSLP is produced by the CD103(+) subset of tolerogenic gut DCs and is downregulated during experimental colitis. TSLP produced by DCs acts directly on T cells by reducing their capacity to produce interleukin (IL)-17 and fostering the development of Foxp3(+) T cells. Consistently, TSLP protects against colitis development through a direct action on T cells, as adoptive transfer of naïve T cells from TSLPR(-/-) to SCID mice results in a more severe colitis, with increased frequency of IL-17-producing T cells and inflammatory cytokines. Hence, we describe a new anti-inflammatory role of TSLP in the gut.
Asunto(s)
Colitis/inmunología , Citocinas/metabolismo , Células Dendríticas/metabolismo , Linfocitos T Reguladores/metabolismo , Células Th17/metabolismo , Traslado Adoptivo , Animales , Antígenos CD/metabolismo , Diferenciación Celular/genética , Células Cultivadas , Colitis/inducido químicamente , Citocinas/genética , Citocinas/inmunología , Células Dendríticas/inmunología , Células Dendríticas/patología , Sulfato de Dextran/administración & dosificación , Progresión de la Enfermedad , Factores de Transcripción Forkhead/metabolismo , Cadenas alfa de Integrinas/metabolismo , Interleucina-17/metabolismo , Intestinos/inmunología , Intestinos/patología , Ratones , Ratones Noqueados , Ratones SCID , Factor 88 de Diferenciación Mieloide/metabolismo , Transducción de Señal/genética , Transducción de Señal/inmunología , Linfocitos T Reguladores/inmunología , Linfocitos T Reguladores/patología , Células Th17/inmunología , Células Th17/patología , Linfopoyetina del Estroma TímicoRESUMEN
A new Schiff base, 9-anthrylidene-furfurylamine and three novel anthracene-containing α-aminophosphonates, [N-methyl(dimethoxyphosphonyl)-1-(9-anthryl)]-p-toluidine, [N-methyl(diethoxyphosphonyl)-1-(9-anthryl)]-p-toluidine and [N-methyl(diethoxyphosphonyl)-1-(9-anthryl)]furfurylamine were synthesized. The compounds have been characterized by elemental analysis, TLC, IR, NMR and fluorescent spectra. The aminophosphonates and their synthetic precursors were tested for in vitro antitumor activity on a panel of seven human epithelial cancer cell lines. Safety testing was performed both in vitro (3T3 NRU test) and in vivo on ICR mice for genotoxicity and antiproliferative activity. 9-Anthrylidene-furfurylamine and [N-methyl(diethoxyphosphonyl)-1-(9-anthryl)]furfurylamine were most potent cytotoxic agents towards colon carcinoma cell line HT-29. The latter compound exhibited also antiproliferative activity to HBL-100, MDA-MB-231 and 647-V cells. The aminophosphonate [N-methyl(dimethoxyphosphonyl)-1-(9-anthryl)]-p-toluidine and its synthetic precursor 9-anthrylidene-p-toluidine were found to be cytotoxic to HBL-100 and HT-29 tumor cell lines, respectively. Moderate genotoxic and antiproliferative activity in vivo and low toxicity to Balb/c 3T3 (clone 31) mouse embryo cells were observed for all tested compounds. The subcellular distribution of two tested compounds in a tumor cell culture system was also studied.
Asunto(s)
Antracenos/química , Antineoplásicos/síntesis química , Antineoplásicos/farmacología , Organofosfonatos/química , Bases de Schiff/química , Bases de Schiff/farmacología , Animales , Antineoplásicos/química , Antineoplásicos/toxicidad , Línea Celular , Proliferación Celular/efectos de los fármacos , Ensayos de Selección de Medicamentos Antitumorales , Humanos , Ratones , Neoplasias/patología , Bases de Schiff/síntesis química , Bases de Schiff/toxicidadRESUMEN
The hypothesis is that the ghrelin signal pathway consists of new participants including a local second mediator in human mesenteric arteries. The contractile force of isometric artery preparations was measured using a wire-myograph. Whole-cell patch clamp experiments were performed on freshly isolated single smooth muscle cells from the same tissue. After the addition of ghrelin (100 nmol) the outward potassium currents conducted through iberiotoxin-sensitive calcium-activated potassium channels with a large conductance were almost entirely abolished. The effect of ghrelin on potassium currents was insensitive to selective inhibitors of cAMP-dependent protein kinase and soluble guanylate cyclase, but was eliminated in the presence of des-octanoyl ghrelin and O-(octahydro-4,7-methano-1H-inden-5-yl) carbonopotassium dithioate (D-609). Ghrelin dose-dependently increased the force of contraction of native, endothelium-denuded and mostly of endothelium-denuded and treated with tetrodotoxin human mesenteric arteries preconstricted with 1 nmol endothelin-1. This effect of ghrelin was blocked when the bath solution contained 1,4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadiene (U0126), 4-amino-5-(4-methylphenyl)-7-(t-butyl) pyrazolo[3,4-d] pyrimidine (PP2), D-609, 2-[1-(3-dimethylaminopropyl)indol-3-yl]-3-(indol-3-yl) maleimide (GF109203x), pertussis toxin, 2-aminoethyl diphenylborinate (2-APB), indomethacin, (5Z,13E)-(9S,11S,15R)-9,15,Dihydroxy-11-fluoro-15-(2-indanyl)-16,17,18,19,20,pentanor-5,13-prostadienoic acid (AL-8810) - a non-selective prostanoid receptor antagonist, 5-(4-Chlorophenyl)-1-(4-methoxyphenyl)-3-trifluoromethyl pyrazolo (SC-560) - a selective cyclooxygenase 1 inhibitor, ozagrel - a selective thromboxane A(2) synthase inhibitor or T prostanoid receptor antagonist GR32191B. It is concluded that ghrelin increases the force of contraction of human mesenteric arteries by a novel mechanism that involves Src kinase, mitogen-activated protein kinase kinase (MEK), cyclooxygenase 1 and T prostanoid receptor agonist, most probably thromboxane A(2).
Asunto(s)
Ghrelina/fisiología , Arterias Mesentéricas/fisiología , Transducción de Señal/fisiología , Anciano , Femenino , Ghrelina/farmacología , Humanos , Masculino , Arterias Mesentéricas/efectos de los fármacos , Arterias Mesentéricas/metabolismo , Persona de Mediana Edad , Transducción de Señal/efectos de los fármacos , Vasoconstricción/efectos de los fármacos , Vasoconstricción/fisiologíaRESUMEN
OBJECTIVE: In mice, a subpopulation of gut dendritic cells (DCs) expressing CD103 drives the development of regulatory T (T(reg)) cells. Further, it was recently described that the cross-talk between human intestinal epithelial cells (IECs) and DCs helps in maintaining gut immune homeostasis via the induction of non-inflammatory DCs. In this study, an analysis was carried out to determine whether IECs could promote the differentiation of CD103+ tolerogenic DCs, and the function of primary CD103+ DCs isolated from human mesenteric lymph nodes (MLNs) was evaluated. METHODS: Monocyte-derived DCs (MoDCs) and circulating CD1c+ DCs were conditioned or not with supernatants from Caco-2 cells or IECs isolated from healthy donors or donors with Crohn's disease and analysed for their ability to induce T(reg) cell differentiation. In some cases, transforming growth factor beta (TGFbeta), retinoic acid (RA) or thymic stromal lymphopoietin (TSLP) were neutralised before conditioning. CD103+ and CD103- DCs were sorted by fluorescence-activated cell sorting (FACS) from MLNs and used in T(reg) cell differentiation experiments. RESULTS: It was found that human IECs promoted the differentiation of tolerogenic DCs able to drive the development of adaptive Foxp3+ T(reg) cells. This control was lost in patients with Crohn's disease and paralleled a reduced expression of tolerogenic factors by primary IECs. MoDCs differentiated with RA or IEC supernatant upregulated the expression of CD103. Consistently, human primary CD103+ DCs isolated from MLNs were endowed with the ability to drive T(reg) cell differentiation. This subset of DCs expressed CCR7 and probably represents a lamina propria-derived migratory population. CONCLUSIONS: A population of tolerogenic CD103+ DCs was identified in the human gut that probably differentiate in response to IEC-derived factors and drive T(reg) cell development.
Asunto(s)
Diferenciación Celular , Células Dendríticas/citología , Intestinos/citología , Linfocitos T Reguladores/citología , Antígenos CD/metabolismo , Células CACO-2/citología , Enfermedad de Crohn/inmunología , Enfermedad de Crohn/patología , Células Dendríticas/inmunología , Células Epiteliales/citología , Células Epiteliales/fisiología , Humanos , Inmunidad Celular , Cadenas alfa de Integrinas/metabolismo , Ganglios Linfáticos/citología , Activación de Linfocitos/inmunologíaRESUMEN
Intestinal dendritic cells (DCs) have been shown to display specialized functions, including the ability to promote gut tropism to lymphocytes, to polarize noninflammatory responses, and to drive the differentiation of adaptive Foxp3(+) regulatory T (T(reg)) cells. However, very little is known about what drives the mucosal phenotype of DCs. Here, we present evidence that the local microenvironment, and in particular intestinal epithelial cells (ECs), drive the differentiation of T(reg)-cell-promoting DCs, which counteracts Th1 and Th17 development. EC-derived transforming growth factor-beta (TGF-beta) and retinoic acid (RA), but not thymic stromal lymphopoietin (TSLP), were found to be required for DC conversion. After EC contact, DCs upregulated CD103 and acquired a tolerogenic phenotype. EC-conditioned DCs were capable of inducing de novo T(reg) cells with gut-homing properties that when adoptively transferred, protected mice from experimental colitis. Thus, we have uncovered an essential mechanism in which EC control of DC function is required for tolerance induction.
Asunto(s)
Colitis/inmunología , Células Dendríticas/inmunología , Mucosa Intestinal/inmunología , Subgrupos de Linfocitos T/inmunología , Linfocitos T Reguladores/inmunología , Animales , Comunicación Celular/inmunología , Diferenciación Celular/inmunología , Colitis/patología , Citocinas/inmunología , Citocinas/metabolismo , Células Dendríticas/metabolismo , Femenino , Tolerancia Inmunológica/inmunología , Interleucina-17/inmunología , Interleucina-17/metabolismo , Activación de Linfocitos/inmunología , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Subgrupos de Linfocitos T/metabolismo , Linfocitos T Reguladores/metabolismo , Factor de Crecimiento Transformador beta/inmunología , Factor de Crecimiento Transformador beta/metabolismo , Tretinoina/inmunología , Tretinoina/metabolismo , Linfopoyetina del Estroma TímicoRESUMEN
In a previous study of the immunoregulatory properties of commensal bacterial DNA, we identified the strong immunostimulatory oligodeoxynucleotide (ISS-ODN) ID35 in the genomic DNA of Lactobacillus rhamnosus GG (LGG). The observed effects of ID35 are because of the unique TTTCGTTT motif located at the 5' end of the ODN, which is different from the previously identified ISS motifs in humans and mice. In the present study, we used an ovalbumin (OVA)-sensitized mouse model to show that ID35 is a potent suppressor of antigen-specific immunoglobulin E (IgE) production in vivo. This effect was toll-like receptor 9-dependent, as GpC negID35 failed to suppress antigen-specific IgE production. ID35 activated the specific subset of CD11c+CD8a+ dendritic cells, which are associated with T-helper 1 (Th1)-type systemic responses, and effectively induced interferon-gamma (IFN-gamma) production by CD4+ T cells in OVA-challenged mice. These immunoregulatory effects of ID35 were comparable with those induced by the murine prototype ODN 1826. Thus, ID35 is the first ISS-ODN with such a strong immunostimulatory and IgE suppressor activity to be found in immunobiotic bacterial DNA.
Asunto(s)
Alérgenos/efectos adversos , Hipersensibilidad/inmunología , Inmunoglobulina E/inmunología , Terapia de Inmunosupresión , Lacticaseibacillus rhamnosus/inmunología , Oligodesoxirribonucleótidos/inmunología , Ovalbúmina/efectos adversos , Alérgenos/administración & dosificación , Secuencias de Aminoácidos , Animales , Especificidad de Anticuerpos , Antígeno CD11c/metabolismo , Linfocitos T CD4-Positivos/inmunología , Antígenos CD8/metabolismo , Células CHO , Cricetinae , Cricetulus , ADN Bacteriano/química , Células Dendríticas/inmunología , Células Dendríticas/metabolismo , Hipersensibilidad/etiología , Hipersensibilidad/metabolismo , Inmunoglobulina E/metabolismo , Inyecciones Intraperitoneales , Interferón gamma/biosíntesis , Interferón gamma/inmunología , Lacticaseibacillus rhamnosus/química , Ratones , Ratones Endogámicos BALB C , Modelos Animales , Oligodesoxirribonucleótidos/administración & dosificación , Oligodesoxirribonucleótidos/síntesis química , Oligodesoxirribonucleótidos/genética , Ovalbúmina/administración & dosificación , Ovalbúmina/inmunología , Probióticos/química , Bazo/inmunología , Receptor Toll-Like 9RESUMEN
AIMS: To find different types of glucosyltransferases (GTFs) produced by Leuconostoc mesenteroides strain Lm 28 and its mutant forms, and to check the effectiveness of gluco-oligosaccharide synthesis using maltose as the acceptor. METHODS AND RESULTS: Constitutive mutants were obtained after chemical mutagenesis by ethyl methane sulfonate. Lm M281 produced more active GTFs than that obtained by the parental strain cultivated on sucrose. GTF from Lm M286 produced a resistant glucan, based on endo-dextranase and amyloglucosidase hydrolysis. The extracellular enzymes from Lm M286 catalyse acceptor reactions and transfer the glucose unit from sucrose to maltose to produce gluco-oligosaccharides (GOS). By increasing the sucrose/maltose ratio, it was possible to catalyse the synthesis of oligosaccharides of increasing degree of polymerization (DP). CONCLUSIONS: Different types of GTFs (dextransucrase, alternansucrase and levansucrase) were produced from new constitutive mutants of Leuc. mesenteroides. GTFs from Lm M286 can catalyse the acceptor reaction in the presence of maltose, leading to the synthesis of branched oligosaccharides. SIGNIFICANCE AND IMPACT OF THE STUDY: Conditions were optimized to synthesize GOS by using GTFs from Lm M286, with the aim of producing maximum quantities of branched-chain oligosaccharides with DP 3-5. This would allow the use of the latter as prebiotics.
Asunto(s)
Reactores Biológicos/microbiología , Glucosiltransferasas/metabolismo , Leuconostoc/genética , Leuconostoc/metabolismo , Oligosacáridos/biosíntesis , Probióticos/metabolismo , Técnicas Bacteriológicas , Cromatografía Líquida de Alta Presión , Dextranasa/metabolismo , Electroforesis en Gel de Poliacrilamida , Metanosulfonato de Etilo , Glicosiltransferasas/metabolismo , Maltosa/metabolismo , Mutación , Oligosacáridos/análisis , Sacarosa/metabolismoRESUMEN
AIMS: The application of endoscope-assisted microsurgery in the treatment of small or medium-sized vestibular schwannomas is of proven value. The goal of our study is to evaluate its usefulness in cases of large schwannomas. PATIENTS AND METHODS: Eighteen patients were included in this prospective study. Their average tumor diameter was 3.9 cm. The retrosigmoid approach was used in all cases. The endoscope was applied during all stages of tumor removal. RESULTS: The facial nerve was visualized endoscopically at early stages of surgery in 9 patients and the abducent nerve in 7 patients. The source of bleeding was identified in 1 case. Tumor remnants in the region of the fundus of the internal auditory canal after apparently total removal were identified in 2 cases. Exposed and unobliterated temporal bone air cells were not observed. DISCUSSION: Even in cases of large schwannomas, the location of the facial nerve can be determined endoscopically early in the procedure. The application of endoscope-assisted microsurgery increases the rate of cranial nerve preservation and of total tumor removal. Although the application of the endoscope did not provide useful information in some cases, it is a safe procedure that did not lead to any complications and/or to considerable prolongation of the operative time. Its application is justified in all cases.
Asunto(s)
Microcirugia/instrumentación , Neuroendoscopios , Neuroma Acústico/patología , Neuroma Acústico/cirugía , Adulto , Anciano , Nervio Facial/patología , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Resultado del Tratamiento , Nervio Vestibulococlear/patologíaRESUMEN
We report a patient with a complex nonreentrant supraventricular tachycardia because of double ventricular response resulting from antegrade dual atrioventricular (AV) nodal pathways. We could induce double ventricular response and confirm dual AV nodal pathways by AV simultaneous pacing during basic stimulation proceeding with programmed atrial single extrastimulation. As far as we know, it is the first report about the application of the AV simultaneous basic stimulation to prove the sustained nonreentrant tachycardia because of simultaneous conduction over dual AV nodal pathways. This was also confirmed by absence of the arrhythmia immediately after the elimination of the slow pathway conduction by radiofrequency ablation.
Asunto(s)
Nodo Atrioventricular/fisiopatología , Ablación por Catéter , Transducción de Señal/fisiología , Taquicardia Supraventricular/fisiopatología , Taquicardia Supraventricular/radioterapia , Función Ventricular/fisiología , Adulto , Técnicas Electrofisiológicas Cardíacas , Femenino , HumanosRESUMEN
The authors have done a biliary retrospective analysis of 10 deceased patients with a diagnosis of biliary peritonitis (BP). It is reported that the patients who died of BP are 9.5% of all who died of diffuse purulent peritonitis. All deceased patients were advanced and well advanced in years with prolonged complaints--in over 50% of them over 5 years. The complications set in 50% of the cases are recorded in the postoperative period. The perforation of the gallbladder and the biliopancreatitis are in the second place. Intrabiliary fistulas with 4 patients and 1 with a vesicocolon fistula; tumor of the pancreas with 4 patients; empyema of the gallbladder--3; diabetes with 3 of the patients and others are recorded as accompanying troubles which complicate the operation and the outcome of it. The time between the beginning of the complication and the operation with all the deceased patients is over 72 hours.
Asunto(s)
Enfermedades del Conducto Colédoco/complicaciones , Peritonitis/complicaciones , Anciano , Anciano de 80 o más Años , Enfermedades del Conducto Colédoco/cirugía , Humanos , Laparotomía/métodos , Persona de Mediana Edad , Monitoreo Intraoperatorio , Peritonitis/cirugíaRESUMEN
Fructo-oligosaccharide represent one of the major classes of bifidogenic oligosaccharides in term of their production volume, because of their favorable functional properties. These include: a/ improving the intestinal microflora; b/ relieving the constipation; c/ decreasing the total cholesterol and lipid in serum; d/ the promotion of animal growth and e/ as low calorie non-cariogenic sweeteners (Chen and Liu, 1996). FOS are manufactured by two differing processes which result in slightly different end products--using either microbial fructosyl transferase (EC 2.4.1.9) or beta-fructofuranosidase (EC 3.2.1.26) with high transfructosylation activity. The present study reports on the biosynthesis of an extracellular inulinase by yeasts from genus Kluyveromyces. The strains were isolated from different dairy products. Some of the studied strains produced large amounts of extracellular inulinase activity when grown on inulin ar sucrose as carbon source. In addition, the effect of C/N ratio on the production of extracellular inulinase was studied. Thin layer chromatography showed that inulinase from K. species 19 was capable of hydrolyzing inulin, releasing monosaccharides and oligosaccharides.
Asunto(s)
Fructosa/metabolismo , Glicósido Hidrolasas/metabolismo , Kluyveromyces/enzimología , Oligosacáridos/metabolismo , Catárticos , Estabilidad de Enzimas , CinéticaRESUMEN
Exopolysaccharides /EPS/ produced by lactic acid bacteria /LAB/ play a role in the rheology and texture of fermented milks (Cerning 1990) and could also provide a new source of safe additives for use in various food products. The physical properties of EPS, such as rheology and behaviour, depend on several factors, including sugar composition, type of sugar linkages, the presence of organic or inorganic substituents, the degree of polymerization and the length of the side chains. On the other hand certain physiological properties of lactic bacteria are of particular importance in the mechanism of their probiotic functioning: metabolism leading to accumulation of organic acids and other fermentation products in the media; resistance to those metabolites; competitive assimilation of the major nutrients of the media. The significant antimicrobial effect of probiotics towards pathogens and potentially pathogenic microorganisms is outlined in this context. This study was conducted on LAB strains with experimentally established preventive effect in control of chemical carcinogenesis induced by dimethylhydrazine, heavy metals and nitrites. The present study reports the biosynthesis of EPS by strains with proved anticancer effect Lactobacillus bulgaricus LB3 and Lactobacillus bulgaricus LBs on whey-based media. A study on the action of different nitrogen sources (yeast extract and peptone) on the productivity of EPS and the rheological properties of medium was done. When whey-based medium was used the highest production of EPS was determined at 1% peptone--145 mg/g(-1). The carbohydrate substrate influenced the EPS composition. Not only the concentration but also the structure of the EPS is important for its thickening effect. The functional properties of the EPS produced could be modified by influencing the growth conditions. The influence of the different content of glucose on the fermentation process and the viscosity of the whey was performed.
Asunto(s)
Medios de Cultivo/química , Productos Lácteos Cultivados , Lactobacillus/metabolismo , Polisacáridos Bacterianos/biosíntesis , Fermentación , Microbiología de Alimentos , Lactobacillus/fisiología , Polisacáridos Bacterianos/química , Polisacáridos Bacterianos/fisiología , Probióticos , ReologíaRESUMEN
Functional foods hold a great promise for future trends in human nutrition. Consumption of milk and milk products have a pronounced probiotic effects together with the expected modification of allergenic properties of milk due to the process of fermentation. The proteolytic system of lactic acid bacteria consists a cell wall bound proteinase and several intracellular peptidases, and can contribute to the liberation of bioactive peptides. Food-derived bioactive peptides are claimed to be health enhancing components which can be used for functional food. In our study we focused our attention on beta-lactoglobulin and alpha-lactalbumin in early stages of yogurt fermentation of traditional Bulgarian products. Biochemical techniques were used to measure the concentration of these two whey proteins during fermentation. At a result of the done study alteration in the concentration of beta-lactoglobulin and alpha-lactalbumin were detected. The studied proteolytic activity of the strains, used in the fermentation process confirmed the received results.
Asunto(s)
Alimentos Orgánicos/análisis , Lactalbúmina/aislamiento & purificación , Lactoglobulinas/aislamiento & purificación , Proteínas de la Leche/aislamiento & purificación , Yogur/análisis , Yogur/microbiología , Fermentación , Microbiología de Alimentos , Hidrólisis , Lactalbúmina/metabolismo , Lactobacillus/crecimiento & desarrollo , Lactobacillus/metabolismo , Lactoglobulinas/metabolismo , Proteínas de la Leche/metabolismo , Fenómenos Fisiológicos de la Nutrición , Streptococcus/crecimiento & desarrollo , Streptococcus/metabolismo , Proteína de Suero de LecheRESUMEN
BACKGROUND: Few researchers have conducted heart rate (HR) studies in healthy very elderly subjects aged 70 years or older, and there are no longitudinal follow-up studies in this population. The objective of this study was to evaluate long-term changes in HR and heart rate variability (HRV) with aging in healthy elderly persons by means of comparison between two Holter monitor recordings obtained at an interval of 15 years. METHODS: The study population consisted of 15 healthy elderly persons (10 women and 5 men) aged 64 to 80 years (mean 70 +/- 4.1) at the first recording, and 79 to 95 years old (mean 85 +/- 4.1 years) at the second recording 15 years later. Nighttime (midnight to 5 AM) and daytime (noon to 5 PM) HR and HRV were obtained, and paired t tests were performed to assess the differences in each parameter of nighttime and daytime HR and HRV between the two (15-year interval) Holter monitor recordings. RESULTS: The results of the t-test comparisons were as follows: there was a significant increase in minimal, maximal, and average HRs (nighttime, p < .01; daytime, p < .05, respectively). On the other hand, with regard to HRV, there was a significant nighttime decrease in the SDNN index (mean of standard deviations of normal RR intervals between adjacent QRS complexes resulting from sinus node depolarizations for all 5-minute segments) (p = .0086), and a significant daytime increase in the NN50 (number of adjacent normal RR intervals >50 milliseconds) per hour (p = .0425). Moreover, there was a significant decrease in the low-frequency (LF) component (nighttime, p = .0151; daytime, p = .0032), and a significant decrease in the LF/HF ratio (nighttime, p = .0270; daytime, p = .0371), but there was no significant change in the nighttime or daytime high-frequency (HF) component. CONCLUSIONS: HR increased with age over the 15-year period in the healthy elderly persons. As for concurrent changes in HRV, however, the parameters of sympathetic modulation decreased, and the parameters of parasympathetic modulation were unchanged or slightly increased.
Asunto(s)
Envejecimiento/fisiología , Frecuencia Cardíaca , Anciano , Anciano de 80 o más Años , Ritmo Circadiano , Electrocardiografía Ambulatoria , Femenino , Humanos , Estudios Longitudinales , Masculino , Valores de ReferenciaRESUMEN
OBJECTIVE: To examine the incidence, underlying disease and clinical features of left ventricular aneurysm (LVA) not related to coronary artery occlusion. METHODS: Retrospective review of consecutive patients who underwent both left ventriculography and coronary angiography. PATIENTS: LVA was confirmed in 11 of 2,348 consecutive patients (0.47%). RESULTS: The location of LVA was mainly in the apical region (81.8%). In five of the 11 patients (45.5%), the underlying heart disease was hypertrophic cardiomyopathy (HCM), including 4 patients of dilated phase and one patient of midventricular type. The serial ECG changes from left ventricular hypertrophy to abnormal Q wave and endomyocardial biopsy were useful for the differential diagnosis of these cases against myocardial infarction. The underlying disease of the remaining patients was: myocarditis (2 patients), arrhythmogenic right ventricular dysplasia (1 patient), Chagas' disease (1 patient), glycogen storage disease (1 patient), and sarcoidosis (1 patient). Ventricular tachycardia appeared in 9 of 11 cases (81.8%) including 2 patients with sustained ventricular tachycardia. CONCLUSION: LVA formation without coronary artery disease was a rare phenomenon. The underlying disease was varied but the incidence of hypertrophic cardiomyopathy in the dilated phase was comparatively high. Ventricular tachycardia was a significant complication in these patients.
Asunto(s)
Aneurisma Cardíaco/diagnóstico , Adulto , Anciano , Displasia Ventricular Derecha Arritmogénica/complicaciones , Cardiomiopatía Hipertrófica/complicaciones , Enfermedad de Chagas/complicaciones , Angiografía Coronaria , Enfermedad Coronaria/diagnóstico por imagen , Electrocardiografía , Femenino , Enfermedad del Almacenamiento de Glucógeno/complicaciones , Aneurisma Cardíaco/etiología , Ventrículos Cardíacos/diagnóstico por imagen , Humanos , Masculino , Persona de Mediana Edad , Miocarditis/complicaciones , Ventriculografía con Radionúclidos , Estudios Retrospectivos , Sarcoidosis/complicacionesRESUMEN
A 31-year-old woman underwent radiofrequency catheter ablation of a concealed left posteroseptal accessory pathway associated with a coronary sinus diverticulum. The patient had previously undergone unsuccessful catheter ablation of the posteroseptal region of the mitral annulus. Coronary sinus venography revealed the presence of the diverticulum near the ostium. An electrogram in the neck of the diverticulum showed the shortest ventriculoatrial conduction time and a large accessory pathway potential during atrioventricular reciprocating tachycardia. The pathway was successfully ablated within the neck of the diverticulum. The findings in this case underscore the importance of coronary sinus venography before ablation.
Asunto(s)
Nodo Atrioventricular/cirugía , Ablación por Catéter/métodos , Anomalías de los Vasos Coronarios/cirugía , Divertículo/cirugía , Adulto , Nodo Atrioventricular/fisiología , Anomalías de los Vasos Coronarios/complicaciones , Divertículo/complicaciones , Femenino , Sistema de Conducción Cardíaco/fisiología , Humanos , Taquicardia Supraventricular/etiología , Taquicardia Supraventricular/cirugíaRESUMEN
The purpose of the study was to compare the effects of DDD pacing with optimal AV delay and AAI pacing on the systolic and diastolic performance at rest in patients with prolonged intrinsic AV conduction (first-degree AV block). We studied 17 patients (8 men, aged 69 +/- 9 years) with dual chamber pacemakers implanted for sick sinus syndrome in 15 patients and paroxysmal high degree AV block in 2 patients. Aortic flow and mitral flow were evaluated using Doppler echocardiography. Study protocol included the determination of the optimal AV delay in the DDD mode and comparison between AAI and DDD with optimal AV delay for pacing rate 70/min and 90/min. Stimulus-R interval during AAI (ARI) was 282 +/- 68 ms for rate 70/min and 330 +/- 98 ms for rate 90/min (P < 0.01). The optimal AV delay was 159 +/- 22 ms. AV delay optimization resulted in an increase of an aortic flow time velocity integral (AFTVI) of 16% +/- 9%. At rate 70/min the patients with ARI < or = 270 ms had higher AFTVI in AAI than in DDD (0.214 +/- 0.05 m vs 0.196 +/- 0.05 m, P < 0.01), while the patients with ARI > 270 ms demonstrated greater AFTVI under DDD compared to AAI (0.192 +/- 0.03 m vs 0.166 +/- 0.02 m, P < 0.01). At rate 90/min AFTVI was higher during DDD than AAI (0.183 +/- 0.03 m vs 0.162 +/- 0.03 m, P < 0.01). Mitral flow time velocity integral (MFTVI) at rate 70/min was higher in DDD than in AAI (0.189 +/- 0.05 m vs 0.173 +/- 0.05 m, P < 0.01), while at rate 90/min the difference was not significant in favor of DDD (0.149 +/- 0.05 m vs 0.158 +/- 0.04 m). The results suggest that in patients with first-degree AV block the relative impact of DDD and AAI pacing modes on the systolic performance depends on the intrinsic AV conduction time and on pacing rate.